4-Ipomeanol
Alternative Names: NSC 349438Latest Information Update: 06 Sep 2011
At a glance
- Originator National Cancer Institute (USA)
- Class Antineoplastics; Furans; Small molecules; Terpenes
- Mechanism of Action Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Liver cancer; Non-small cell lung cancer
Most Recent Events
- 06 Sep 2011 Discontinued - Phase-I for Non-small cell lung cancer in USA (IV)
- 06 Sep 2011 Discontinued - Phase-II for liver cancer in USA (IV)
- 18 Sep 2001 Phase-II clinical trials for liver cancer in USA (IV)